ICON PLC
ICLRNASDAQTrading Snapshot
- Day Range
- $195.99 โ $214.62
- 52-Week Range
- $66.57 โ $203.91
- Volume (shares)
- 3,944,352
- Avg Volume (shares)
- โ
- Shares Outstanding
- 77.2M
- Next Earnings
- 2027-02-24
Fundamentals Snapshot
- Annual Revenue
- $8.25B
- Last Q Revenue
- $2.06B
- P/E Ratio
- 204.6
- P/S Ratio
- 1.7x
- EPS (TTM)
- $0.90
- Dividend Yield
- โ
- Dilution (1yr)
- โ4.0%
ICON PLC
ICLRAbout ICON PLC
ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also provides clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient access services; clinical trial management, consulting, and contract staffing services; and commercial services comprising clinical development strategy, planning and trial design, full study execution, and post-market commercialization. In addition, the company offers laboratory services, including bionanalytical, biomarker, vaccine, good manufacturing practice, and central laboratory services, as well as full-service and functional service partnerships to customers. Further, the company provides adaptive trials, cardiac safety solutions, clinical and scientific operations, consulting and advisory, commercial positioning, decentralized and hybrid clinical trials, early clinical, laboratories, language services, medical imaging, real world intelligence, site and patient, and strategic solutions. It serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. The company has a strategic alliance with Advarra, Inc. for the development of a connected, research-ready clinical trial site network model. ICON Public Limited Company was incorporated in 1989 and is headquartered in Dublin, Ireland.
Otter Score Breakdown
How it's scoredFive components, each rated 1โ5โ and equally weighted (20%), averaged to a 0โ100 score:๐ Quality โ gross margin๐ Growth โ revenue YoYโ๏ธ Valuation โ P/S ratioโก Momentum โ 30-day price change๐ง Dilution โ 1-yr share issuance (buybacks score higher)Analyst Ratings
โLatest News & Updates
ICON Public Limited Company (ICLR) Q3 2026 Earnings Call Transcript
ICON Public Limited Company ( ICLR ) Q3 2026 Earnings Call October 28, 2026 8:00 AM EDT Company Participants Kate Haven - Vice President of Investor Relations Barry Balfe - CEO & Director Nigel Clerkin - Chief Financial
What Icon (ICLR) Said on Its Q3 Earnings Call
Icon NASDAQ: ICLR reported third-quarter 2026 results that management said were in line with expectations, citing record net business wins, improving margins and continued investment in technology-enabled clinical develo
Icon PLC (ICLR) Q3 Earnings and Revenues Beat Estimates
Icon PLC (ICLR) came out with quarterly earnings of $2.66 per share, beating the Zacks Consensus Estimate of $2.64 per share. This compares to earnings of $3.31 per share a year ago.

Riverwater Partners Sustainable Value Strategy Q3 2026 Portfolio Update
The Sustainable Value Strategy trailed its benchmark, the Russell 2500 Value Index, in the third quarter. New positions include Lineage, Birkenstock, Matador Resources, KBR and ICON. InterDigital, Stevanato Group and Exe

Build-A-Bear Workshop Unveils Three Specialty Shop Experiences Coming to New ICON Park Orlando Destination on Nov. 5
All-new immersive spaces featuring Pokรฉmon, Hello Kittyยฎ and Friends, and Promise Petsโข will debut when Build-A-Bear is scheduled to open its most iconic experience on Nov. 5 ST. LOUIS, Oct. 20, 2026 /PRNewswire/ -- Buil
Analysts Estimate Icon PLC (ICLR) to Report a Decline in Earnings: What to Look Out for
Icon PLC (ICLR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.